uce
ProgressImage ProgressImage
Alpa Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 532878 border-img ISIN Demat INE385I01010 border-img Book Value 83.05 border-img NSE Symbol ALPA border-img Div & Yield % 0 border-img Market Cap ( Cr.) 212.19 border-img P/E 8.43 border-img EPS 11.96 border-img Face Value 10
Quarters
ParticularsDec 2024
()
Sep 2024
()
Jun 2024
()
Gross Sales26.1524.9421.44
Other Operating Income0.000.000.00
Other Income 8.806.915.18
Total Income34.9531.8526.62
Total Expenditure 25.4121.6720.90
PBIDT9.5410.185.72
Interest 0.100.060.05
PBDT9.4410.125.67
Depreciation0.550.530.54
Tax0.001.960.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax8.897.635.12
Extra-ordinary Items 0.000.000.02
Adjusted Profit After Extra-ordinary item8.897.635.10
    
EPS (Unit Curr.)4.243.632.44
EPS (Adj) (Unit Curr.)4.243.632.44
Calculated EPS (Unit Curr.)4.233.632.44
Calculated EPS (Adj) (Unit Curr.)4.233.632.44
Calculated EPS (Ann.) (Unit Curr.)16.9114.509.74
Calculated EPS (Adj) (Ann.) (Unit Curr.)16.9114.509.74
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity21.0421.0421.04
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)36.4840.8226.68
PBDTM(%)36.1040.5826.45
PATM(%)34.0030.5923.88
x
x
×
Let's Chat
close
refresh